Foreign multinational company production on the sharp rise.

Published: 2001-07-31 07:00:00

Updated: 2001-07-31 07:00:00

Many foreign multinational pharmaceutical corporations unprecedently enjoyed their business operation in Korea with their own developed branded drugs, producing a whopping stance after implementation of the medical reform program and swallowing quite a rate of local market shares.

The KPMA's p...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK